Daniela Sachsenheimer

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Clinical assessment of the accuracy of blood glucose measurement devices

Andreas Pfützner, Michael Mitri, Petra B. Musholt et al. · Current Medical Research and Opinion · 2012 · 64 citations

Using Insulin Infusion Sets in CSII for Longer Than the Recommended Usage Time Leads to a High Risk for Adverse Events

Andreas Pfützner, Daniela Sachsenheimer, Marco Grenningloh et al. · Journal of Diabetes Science and Technology · 2015 · 49 citations · Full text

Impact of Xylose on Glucose-Dehydrogenase-Based Blood Glucose Meters for Patient Self-Testing

Andreas Pfützner, Filiz Demircik, Daniela Sachsenheimer et al. · Journal of Diabetes Science and Technology · 2016 · 14 citations · Full text

Xylose Amount, Diabetes Management, Patient Self-testing +15